Ray Dalio's PRVA Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 237,948 shares of Privia Health Group, Inc. (PRVA) worth $4.89 M, representing 0.02% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in PRVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 159,991 shares. Largest reduction occurred in Q3 2024, reducing 45,829 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Privia Health Group (PRVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Privia Health Group (PRVA) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +27,934 | Add 13.30% | 237,948 | $20.57 |
| Q4 2025 | +159,991 | Add 319.83% | 210,014 | $23.71 |
| Q3 2025 | +50,023 | New Buy | 50,023 | $24.90 |
| Q1 2025 | -12,318 | Sold Out | 0 | $0.00 |
| Q4 2024 | -28,797 | Reduce 70.04% | 12,318 | $19.55 |
| Q3 2024 | -45,829 | Reduce 52.71% | 41,115 | $18.21 |
| Q2 2024 | -13,766 | Reduce 13.67% | 86,944 | $17.38 |
| Q1 2024 | -14,580 | Reduce 12.65% | 100,710 | $19.59 |
| Q4 2023 | -11,826 | Reduce 9.30% | 115,290 | $23.03 |
| Q3 2023 | +19,584 | Add 18.21% | 127,116 | $23.00 |
| Q2 2023 | +34,288 | Add 46.81% | 107,532 | $26.11 |
| Q1 2023 | +3,793 | Add 5.46% | 73,244 | $27.61 |
| Q4 2022 | -8,504 | Reduce 10.91% | 69,451 | $22.71 |
| Q3 2022 | +2,679 | Add 3.56% | 77,955 | $34.06 |
| Q2 2022 | +9,238 | Add 13.99% | 75,276 | $29.12 |
| Q1 2022 | +16,616 | Add 33.62% | 66,038 | $26.73 |
| Q4 2021 | -28,170 | Reduce 36.31% | 49,422 | $25.88 |
| Q3 2021 | +77,592 | New Buy | 77,592 | $23.56 |
Ray Dalio's Privia Health Group Investment FAQs
Ray Dalio first purchased Privia Health Group, Inc. (PRVA) in Q3 2021, acquiring 77,592 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Privia Health Group, Inc. (PRVA) for 18 quarters since Q3 2021.
Ray Dalio's largest addition to Privia Health Group, Inc. (PRVA) was in Q4 2025, adding 210,014 shares worth $4.98 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 237,948 shares of Privia Health Group, Inc. (PRVA), valued at approximately $4.89 M.
As of the Q1 2026 filing, Privia Health Group, Inc. (PRVA) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Privia Health Group, Inc. (PRVA) was 237,948 shares, as reported at the end of Q1 2026.